Profit Or Loss [Abstract]

Ascelia Pharma - Filing #678716

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	- SEK	—	—	—	—	—	—	- SEK	—	—	—	—
Other income	—	—	1 587 SEK	—	—	—	—	—	—	827,000 SEK	—	—	—	—
Profit (loss) from operating activities	—	—	110 914 SEK	—	—	—	—	—	—	147 007 SEK	—	—	—	—
Finance income	—	—	3 725 SEK	—	—	—	—	—	—	17 816 SEK	—	—	—	—
Finance costs	—	—	2 418 SEK	—	—	—	—	—	—	3 965 SEK	—	—	—	—
Profit (loss) before tax	—	—	109 607 SEK	—	—	—	—	—	—	133 155 SEK	—	—	—	—
Tax expense (income)	—	—	319,000 SEK	—	—	—	—	—	—	1 933 SEK	—	—	—	—
Profit (loss)	- SEK	- SEK	109 288 SEK	- SEK	109 288 SEK	109 288 SEK	- SEK	- SEK	131 223 SEK	131 223 SEK	131 223 SEK	- SEK	- SEK	- SEK
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	109 288 SEK	—	—	—	—	—	—	131 223 SEK	—	—	—	—
Profit (loss), attributable to non-controlling interests	—	—	- SEK	—	—	—	—	—	—	- SEK	—	—	—	—
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	—	324.00	—	—	—	—	—	—	377.00	—	—	—	—